Uppsala 28th January 2020


Nanexa recruits CFO

Nanexa has recruited Björn Svanström as Chief Financial Officer (CFO) of the company. Björn has extensive experience in finance and the capital market, from roles such as advisors in corporate finance, group controller in listed company, CEO of investment companies and in recent years as CFO of development companies in similar capital-intensive phase as Nanexa.

Nanexa’s CEO David Westberg comments:

It is a natural step for Nanexa as a listed company to now recruit a CFO, especially in the light of increasing activity on the operational side with the external collaborations initiated in 2019 and its own project NEX-18.

We are in an intensive phase in the Company and by recruiting Björn we gain increased competence and capacity in the financial area and we also free up time for me to devote more work to commercialization and development of Nanexa.

For further information:

Nanexa AB (publ)

David Westberg, VD

Phone: +46 709 42 83 03

E mail:


About Nanexa AB (publ)

Nanexa AB is a nanotechnology drug delivery company focusing on the development of PharmaShell®, which is a new and groundbreaking drug delivery system that is expected to have great potential in a number of medical indications. Within the framework of PharmaShell®, Nanexa has partnership agreements with among others, AstraZeneca.